Harvey et al., 1997 - Google Patents
Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and …Harvey et al., 1997
View PDF- Document ID
- 41400836210754459
- Author
- Harvey S
- Nayak S
- Markus G
- Ouhammouch M
- Hemperly J
- Dillman R
- Doyle D
- Publication year
- Publication venue
- Archives of biochemistry and biophysics
External Links
Snippet
We have previously reported on the secretion of a family of highMrplasminogen activators (PAs) by a human lung cancer cell line [Harveyet al.(1991) Biochim. Biophys. Acta1078, 360– 368]. We have now extended these studies to several human cancer cell lines and a human …
- 210000004027 cells 0 title abstract description 70
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| White et al. | The isolation and characterization of plasminogen activators (urokinase) from human urine | |
| Sekiguchi et al. | Domain structure of hamster plasma fibronectin. Isolation and characterization of four functionally distinct domains and their unequal distribution between two subunit polypeptides. | |
| Hajjar | The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen. | |
| Hauri et al. | Monoclonal antibodies to sucrase/isomaltase: probes for the study of postnatal development and biogenesis of the intestinal microvillus membrane. | |
| US4446122A (en) | Purified human prostate antigen | |
| Solberg et al. | A cleaved form of the receptor for urokinase‐type plasminogen activator in invasive transplanted human and murine tumors | |
| HØYER-HANSEN et al. | Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor | |
| Kuhajda et al. | Expression of haptoglobin-related protein and its potential role as a tumor antigen. | |
| McCaughan et al. | Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: An analysis by tissue distribution, purification and N‐terminal amino acid sequence | |
| Spiegelberg et al. | Structural studies of human γD myeloma protein | |
| KITAHARA et al. | Large-scale purification of porcine calpain I and calpain II and comparison of proteolytic fragments of their subunits | |
| USRE33405E (en) | Purified human prostate antigen | |
| Koistinen et al. | Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d | |
| EP0454782B1 (en) | Cancer related haptoglobin (hpr) | |
| Gramzow et al. | Identification and further characterization of the specific cell binding fragment from sponge aggregation factor. | |
| Edwards et al. | Antibodies to a synthetic peptide that react specifically with a common surface region on two hydrocarbon-inducible isoenzymes of cytochrome P-450 in the rat | |
| Harvey et al. | Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and Haptoglobin α and β Chains | |
| Kurkela et al. | Preparation of F (ab′) 2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging | |
| Bhattacharya et al. | Identification of a human cancer-associated antigen defined with monoclonal antibody | |
| Ripoche et al. | Two populations of complement factor H differ in their ability to bind to cell surfaces | |
| Matsumoto et al. | Functional analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies. | |
| WO1994011508A3 (en) | Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods | |
| WO1981001849A1 (en) | Purified human prostate antigen | |
| JPH06505496A (en) | Compositions and methods for inhibiting activation of active factor X111 | |
| KR930002834B1 (en) | Anti-urokinase monoclonal antibody bearing matrix capable of separating and puritying workinase from biological sources |